Novartis:6
halts:2
malaria:4
drug:7
trial:6
against:8
COVID19:9
amid:3
participant:2
shortfall:1
Reuters:5
Discover:1
Thomson:3
ReutersFinancialGovernment:1
SolutionsLegalReuters:1
News:1
AgencyRisk:1
Management:1
SolutionsTax:1
AccountingBlog:1
Answers:1
OnInnovation:1
ReutersDirectory:1
of:13
sitesLoginContactSupportBusinessMarketsWorldPoliticsTVMoreUnited:1
States:2
Health:2
NewsJune:1
19:1
2020:3
917:1
PM:1
in:12
3:1
daysNovartis:1
shortfallJohn:1
Miller3:1
Min:1
ReadZURICH:1
Swiss:1
drugmaker:2
NOVNS:1
is:1
halting:1
its:6
hydroxychloroquine:6
HCQ:4
after:2
struggling:1
to:11
find:1
participants:1
it:9
said:4
on:2
Friday:1
as:4
data:2
emerged:1
from:2
other:1
studies:3
raising:1
doubts:1
about:2
efficacy:3
FILE:1
PHOTO:1
A:1
pharmacist:1
displays:1
a:9
box:1
Hydroxychloroquine:2
at:1
the:14
CHR:1
Centre:1
Hospitalier:1
Regional:1
de:1
la:1
Citadelle:1
Hospital:1
coronavirus:3
disease:1
Liege:1
Belgium:1
June16:1
REUTERSYves:1
HermanFile:1
PhotoNovartis:1
began:1
April:1
and:8
sought:1
test:1
440:1
hospitalized:1
patients:4
But:1
project:1
only:1
managed:1
recruit:1
handful:1
move:1
follows:1
this:1
weeks:1
US:2
Food:1
Drug:1
Administrations:1
FDA:3
decision:3
revoke:2
emergency:2
use:2
authorization:2
for:3
grounds:1
related:1
chloroquine:1
are:1
unlikely:2
help:1
also:2
used:2
treat:1
inflammatory:1
disorders:1
including:3
rheumatoid:1
arthritis:1
lupus:1
has:4
been:2
caught:1
political:1
debate:1
President:1
Donald:1
Trump:2
promoted:1
even:1
though:1
there:1
was:2
no:3
scientific:1
evidence:1
that:2
helps:1
new:2
Several:1
decadesold:1
Britain:1
were:1
recently:1
halted:2
scientists:1
concluded:1
useless:1
This:1
week:1
World:1
Organization:1
arm:1
one:1
trials:3
The:3
recruitment:2
challenge:1
facing:1
our:1
made:1
clinical:1
team:1
will:1
be:1
able:1
collect:1
meaningful:1
reasonable:1
time:1
frame:1
determine:1
treating:1
with:4
who:1
he:1
prophylactic:1
criticized:1
Baselbased:1
company:1
study:1
so:1
far:1
raised:1
safety:1
issues:1
drew:1
conclusions:1
HCQs:1
coincided:1
increasing:1
Gilead:1
Sciences:1
GILDO:1
remdesivir:2
which:2
shown:1
speed:1
recovery:1
warned:1
mixing:1
French:1
Sanofi:1
SASYPA:1
previously:1
suspended:1
two:2
told:1
would:2
make:1
coming:1
days:1
over:1
whether:1
resume:1
own:1
had:1
donated:1
up:1
130:1
million:1
doses:1
millions:1
United:1
Chief:1
Executive:1
Vas:1
Narasimhan:1
months:1
ago:1
pegged:1
companys:1
biggest:1
hope:1
Reporting:1
by:2
John:1
Miller:1
Matthias:1
Blamont:1
Paris:1
Editing:1
Cynthia:1
OstermanOur:1
StandardsThe:1
Trust:1
Principles0:1
0narrowbrowserandphonemediumbrowserandportraittabletlandscapetabletmediumwidebrowserwidebrowserandlargermediumbrowserandlandscapetabletmediumwidebrowserandlargerabovephoneportraittabletandaboveaboveportraittabletlandscapetabletandabovelandscapetabletandmediumwidebrowserportraittabletandbelowlandscapetabletandbelowAppsNewslettersAdvertise:1
UsAdvertising:1
GuidelinesCookiesTerms:1
UsePrivacyAll:1
quotes:1
delayed:1
minimum:1
15:1
minutes:1
See:1
here:1
complete:1
list:1
exchanges:1
delays:1
All:1
Rights:1
Reserved:1
